Bifogade filer
PDF
Kurs
+3,50%
Likviditet
1,50 MSEK
Kalender
| Est. tid* | ||
| 2026-02-26 | 08:30 | Bokslutskommuniké 2025 |
| 2025-11-28 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-28 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-06-19 | N/A | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2025-06-18 | N/A | Årsstämma |
| 2025-05-22 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2024-11-28 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-27 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-20 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2024-06-19 | - | Årsstämma |
| 2024-05-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-06 | - | Extra Bolagsstämma 2024 |
| 2024-03-05 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-19 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2023-06-16 | - | Årsstämma |
| 2023-05-24 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-01 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2022-05-31 | - | Årsstämma |
| 2022-05-24 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-31 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-31 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2021-05-28 | - | Årsstämma |
| 2021-05-20 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-27 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2020-05-26 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-29 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-29 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2019-05-28 | - | Årsstämma |
| 2019-05-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-15 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-29 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-01 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2018-05-31 | - | Årsstämma |
| 2018-05-15 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-11-23 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-06-01 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2017-05-31 | - | Årsstämma |
| 2017-05-31 | - | Kvartalsrapport 2017-Q1 |
| 2017-05-24 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-23 | - | Bokslutskommuniké 2016 |
| 2016-11-24 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-24 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2016-05-23 | - | Årsstämma |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-25 | - | Bokslutskommuniké 2015 |
| 2015-11-25 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-29 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2015-05-28 | - | Årsstämma |
| 2015-05-25 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-26 | - | Bokslutskommuniké 2014 |
| 2014-11-24 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-22 | - | Årsstämma |
| 2014-05-22 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-28 | - | Bokslutskommuniké 2013 |
| 2013-11-29 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-26 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-28 | - | Split AXIC A 4:1 |
| 2013-05-30 | - | Kvartalsrapport 2013-Q1 |
| 2013-05-21 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2013-05-20 | - | Årsstämma |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2012-11-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-30 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-28 | - | Kvartalsrapport 2012-Q1 |
| 2012-05-17 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2012-05-16 | - | Årsstämma |
| 2012-02-29 | - | Bokslutskommuniké 2011 |
| 2011-11-28 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-30 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-30 | - | Kvartalsrapport 2011-Q1 |
| 2011-05-10 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
| 2011-05-09 | - | Årsstämma |
| 2011-02-25 | - | Bokslutskommuniké 2010 |
| 2010-05-11 | - | X-dag ordinarie utdelning AXIC A 0.00 SEK |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Material |
| Industri | Plast, kemikalier & fetter |
aXichem AB (https://www.axichem.com/) (publ), which develops and markets natural analogue industrial chemicals, announces that it expects significantly increased sales over the next twelve months of the company's natural analogue product phenylcapsaicin in the area of dietary supplements and nutraceuticals, where the product is marketed under the brand name aXivite (https://axivite.com/)®. In the last two years, aXichem has built up a network of distributors in Europe and the USA and conducted studies that confirmed aXivite's positive effect in terms of weight control and physical training. The data has been presented in white papers and articles, which have been well received by manufacturers of dietary supplements and increased interest in aXivite. In the US, products with aXivite as an active ingredient have been launched at leading retailers such as GNC (https://www.gnc.com/stimulant-thermogenics/403780.html) (General Nutrition Corporation) and Amazon. The company therefore assesses that continued positive development for aXivite can result in revenues of approximately SEK 20-25 million over the next twelve months.
"aXivite is marketed and sold by a highly professional network of distributors in the US and Europe. We have built up the market for this brand new product and so far have seen steadily increasing sales. aXichem today has the raw material to supply the demand we see and it will be very exciting to work further together with our distributors and continue to build the market for our unique product," says Torsten Helsing, CEO of aXichem.
About phenylcapsaicin and aXivite
aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, connected by a triple bond. The result is an innovative natural analog capsaicin with high purity, which in several studies has been shown to have the same health-promoting properties, as well as some unique benefits, as natural capcaisin. Phenylcapsaicin is approved under Novel Food in the EU and GRAS Food in the USA and is marketed for dietary supplements and functional foods under the brand name aXivite.
This information is such that aXichem AB is obliged to publish in accordance with the EU Market Abuse Regulation. The information was submitted, through the care of the contact person below, for publication on 7 February 2023, at 08:45 AM CET.
Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se